相关实验视频
Updated: Jun 16, 2026

Zebrafish Model of Neuroblastoma Metastasis
Published on: March 14, 2021
神经母细胞瘤中17q的增加:临床和生物学影响的审查
Vid Mlakar1, Isabelle Dupanloup1,2, Fanny Gonzales1,3
1Cansearch Research Platform for Pediatric Oncology and Hematology, Faculty of Medicine, Department of Pediatrics, Gynecology and Obstetrics, University of Geneva, Rue Michel Servet 1, 1211 Geneva, Switzerland.
17q增加是神经母细胞瘤 (NB) 中常见的遗传变化,这是一个常见的儿童癌症. 本综述强调了其作为临床标志物的重要性,特别是区分整体与部分增益.
科学领域:
- 儿科瘤学 儿科瘤学
- 癌症基因组学 癌症基因组学
- 分子生物学分子生物学
背景情况:
- 神经母细胞瘤 (NB) 是最常见的儿童脑外固体瘤.
- 尽管治疗进展,高风险的NB仍有不良预后.
- 17q增益是NB中最常见的基因组变异,但由于与其他不良预后标志物同时发生,其重要性受到争论.
研究的目的:
- 审查神经母细胞瘤中17q增加的临床和生物学意义.
- 评估17q增益作为儿科癌症的预后标志物.
- 澄清17q增益驱动瘤发生过程中特定断点和相关基因的作用.
主要方法:
- 关于神经母细胞瘤中17q增长的研究的综合文献综述.
- 分析现有证据,将17q增益与临床结果和生物机制联系起来.
- 检查与17q增益相关的遗传断点和候选瘤基因.
主要成果:
- 17q的增加与NB的发展有很大关系,并作为临床相关的标记物.
- 区分全染色体17q和部分染色体17q的增加至关重要.
- 在17q12和17q21的突破点是显著的,17q21包含关键的癌基因,如IGF2BP1和NME1.1.
结论:
- 17q的增加是神经母细胞瘤发病的一个重要因素.
- 17q增益的特定模式,特别是涉及17q21的部分增益,对于理解NB预后至关重要.
- IGF2BP1和NME1可能是驱动NB17q增益的功能影响的关键瘤基因.
更多相关视频
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
相关概念视频
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...